All the tech products we use are going to get “thinner and lighter,” Toshiba Americas President Mark Simons told Cheddar.
In tandem with that, Simons predicts that the “convertible [will] really take over and possibly even outpace the traditional clamshell product.” He says we’ll also see major shifts in the tech we wear.
All those trends will “really start to change our work life.”
Toshiba was once a prominent market leader. But in recent years, the Japanese electronics conglomerate has been losing a lot of ground to competition.
Amid problems with its U.S. nuclear business, the company had to sell off its flagship chipmaking arm. It’s also shifted away from making consumer electronics, focusing on enterprise products instead.
Simons told Cheddar that Toshiba will soon announce products that will “empower those workers who haven’t had technology in the past,” though he didn’t give away any further details on those plans.
For the full interview, [click here](https://cheddar.com/videos/toshiba-shifts-focus).
Former Medtronic CEO and author of 'True North' Bill George explains the steps Boeing leadership must take to regain client and consumer trust after 737 Max 9 production was stopped.
Amazon blamed "regulatory hurdles" for calling off its proposed acquisition of robot vacuum maker iRobot. Not even a Roomba could clean up the deal's antitrust scrutiny.
To celebrate Flutter Entertainment's debut on the NYSE, FanDuel CEO Amy Howe shares her thoughts on the company's plans for growth, the future of online sportsbetting, and Super Bowl Sunday.
Investopedia's Caleb Silver shares thoughts on the upcoming Fed meeting, why individual investors are still slightly skeptical, and what he's looking for from mega cap tech earnings.
Season's greetings! Tax season, that is. January 29 is the first day you can file your tax return. We walk you through each step — plus a checklist you can download.
The Q-Collar helps protect athletes from impact-related concussions. Now, the U.S. Army is evaluating if the device could help reduce traumatic brain injury cased by blast weapons.
Co-founder and executive chairman of the board at Vaxxinity Lou Reese shares how the company is working to bring vaccines for chronic illnesses like heart disease and Parkinson’s to market with an eye for accessibility.
Mario Veneroso, Kingsview Asset Management Partner, weighs in on the latest economic data and whether the market is pricing in too many rate cuts for the coming year.
